Search
Search Results
##search.searchResults.foundPlural##
-
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3360PDF: 2282HTML: 23347Untitled: 208Untitled: 220Untitled: 238 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3260PDF: 1460HTML: 5953Fig1-Ag-Pil: 234Ag-Pil Fig.2: 237 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1861PDF: 783HTML: 528 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9144PDF: 6092HTML: 87969Fig.1b: 191Fig.1c: 197Fig.2a: 184Fig.2b: 181Fig.4: 194Fig.2c: 190Fig.3: 188Tab.1: 236Tab.2: 214Tab.3: 195Tab.4: 229Fig1a: 193 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1402HTML: 474PDF: 834 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1584PDF: 398HTML: 214 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1819PDF: 991HTML: 147 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4840PDF: 1815HTML: 2164 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3580PDF: 2509HTML: 1496 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1135PDF: 500HTML: 243 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1196PDF: 765HTML: 1369Figure 1: 194Figure 2: 195 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3347PDF: 1148HTML: 448 -
Anemia in the elderly: not always what it seems.
3332PDF: 1076HTML: 1783Figure 1: 184Figure 1 revised: 185 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1242PDF: 532HTML: 226 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1319PDF: 880HTML: 1145Coverletter: 209 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3581PDF: 1203HTML: 5004Incidence age-standardized rates for HL across the Mediterranean basin: 208 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12399PDF: 1683HTML: 4207Cover letter: 204Figure 1: 212 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1261PDF: 1014HTML: 224 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1807PDF: 711HTML: 398 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2167PDF: 1719HTML: 383 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1726PDF: 1200HTML: 234 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1875HTML: 1479PDF: 1109 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3053PDF: 916HTML: 2030 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3330PDF: 1249HTML: 2208 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
987PDF: 597HTML: 365 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1488PDF: 918HTML: 2215Response to reviewers comments: 186







